Literature DB >> 2479021

Interleukin 6 induces a liver-specific nuclear protein that binds to the promoter of acute-phase genes.

V Poli1, R Cortese.   

Abstract

Interleukin 6 (IL-6) is responsible for a variety of biological effects related to the activation of defenses against infection or inflammation, including the immune response and the acute-phase reaction. Its mechanism of action is unknown. It has recently been shown to induce transcription of several genes encoding acute-phase proteins. Here we describe the identification of an IL-6 responsive element (IL-6RE) present in the promoter of the human hemopexin gene. This element is necessary and sufficient for the IL-6-dependent activation of transcription. The IL-6 effect does not require de novo protein synthesis. A liver-specific nuclear protein (IL-6DBP) binds to the hemopexin IL-6RE as well as to similar sequences on the promoter of other acute-phase genes. IL-6DBP DNA binding activity is induced by IL-6 via a posttranslational mechanism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479021      PMCID: PMC298248          DOI: 10.1073/pnas.86.21.8202

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  The primary structure of human hemopexin deduced from cDNA sequence: evidence for internal, repeating homology.

Authors:  F Altruda; V Poli; G Restagno; P Argos; R Cortese; L Silengo
Journal:  Nucleic Acids Res       Date:  1985-06-11       Impact factor: 16.971

2.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

3.  Determinants of rat albumin promoter tissue specificity analyzed by an improved transient expression system.

Authors:  J M Heard; P Herbomel; M O Ott; A Mottura-Rollier; M Weiss; M Yaniv
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

4.  Short and long range activation by the SV40 enhancer.

Authors:  B Wasylyk; C Wasylyk; P Chambon
Journal:  Nucleic Acids Res       Date:  1984-07-25       Impact factor: 16.971

5.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

6.  Common and interchangeable elements in the promoters of genes transcribed by RNA polymerase iii.

Authors:  G Ciliberto; G Raugei; F Costanzo; L Dente; R Cortese
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

7.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

8.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

9.  The human haptoglobin gene: transcriptional regulation during development and acute phase induction.

Authors:  S Oliviero; G Morrone; R Cortese
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

10.  B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-beta 2, HPGF).

Authors:  P Poupart; P Vandenabeele; S Cayphas; J Van Snick; G Haegeman; V Kruys; W Fiers; J Content
Journal:  EMBO J       Date:  1987-05       Impact factor: 11.598

View more
  43 in total

1.  Cooperative effects of C/EBP-like and NF kappa B-like binding sites on rat serum amyloid A1 gene expression in liver cells.

Authors:  X Li; W S Liao
Journal:  Nucleic Acids Res       Date:  1992-09-25       Impact factor: 16.971

2.  A novel cis-acting element is essential for cytokine-mediated transcriptional induction of the serum amyloid A gene in nonhepatic cells.

Authors:  A Ray; B K Ray
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  Liver specific transcription factors of the HNF3-, C/EBP- and LFB1-families interact with the A-activator binding site.

Authors:  T Drewes; L Klein-Hitpass; G U Ryffel
Journal:  Nucleic Acids Res       Date:  1991-12-11       Impact factor: 16.971

4.  C/EBP-like proteins binding to the functional box-alpha and box-beta of the second enhancer of hepatitis B virus.

Authors:  C H Yuh; L P Ting
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

Review 5.  Drugs affecting plasma fibrinogen levels.

Authors:  G di Minno; M Mancini
Journal:  Cardiovasc Drugs Ther       Date:  1992-02       Impact factor: 3.727

6.  Regulation of mouse serum amyloid A gene expression in transfected hepatoma cells.

Authors:  J H Huang; H Y Rienhoff; W S Liao
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

7.  The two C/EBP isoforms, IL-6DBP/NF-IL6 and C/EBP delta/NF-IL6 beta, are induced by IL-6 to promote acute phase gene transcription via different mechanisms.

Authors:  D P Ramji; A Vitelli; F Tronche; R Cortese; G Ciliberto
Journal:  Nucleic Acids Res       Date:  1993-01-25       Impact factor: 16.971

Review 8.  Regulation of serum amyloid A protein expression during the acute-phase response.

Authors:  L E Jensen; A S Whitehead
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

9.  Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity.

Authors:  C Scheid; R Young; R McDermott; L Fitzsimmons; J H Scarffe; P L Stern
Journal:  Cancer Immunol Immunother       Date:  1994-02       Impact factor: 6.968

10.  Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction.

Authors:  B Stein; P C Cogswell; A S Baldwin
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.